Glycitein Mitigates Doxorubicin‐Induced Cardiotoxicity by Mitigating Apoptosis and Inflammatory Responses in Albino Rats

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of biochemical and molecular toxicology

• Publication date

  2025-09-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1002/jbt.70489PMID 40936427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An Insight into Absorption, Distribution, Metabolism, Excretion, and Toxicity Screening, Molecular Dynamic Simulation, and Molecular Docking of Glycitein as Hepatoprotective Isoflavone

  2024cited by this paper
• The combination of high uric acid and high C-reactive protein increased the risk of cardiovascular disease: A 15-year prospective cohort study.

  2024cited by this paper
• Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy

  2023cited by this paper
• 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).

  2022cited by this paper
• Glycitein exerts neuroprotective effects in Rotenone-triggered oxidative stress and apoptotic cell death in the cellular model of Parkinson's disease.

  2022cited by this paper
• Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents

  2022cited by this paper
• Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association

  2022cited by this paper
• Immune Checkpoint Inhibitors Related to Cardiotoxicity

  2022cited by this paper
• Mechanism of Glycitein in the Treatment of Colon Cancer Based on Network Pharmacology and Molecular Docking

  2022cited by this paper
• The innate immune response in myocarditis.

  2021cited by this paper
• Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.

  2021cited by this paper
• Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology

  2021cited by this paper
• Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management.

  2021cited by this paper
• Cancer Therapy-Related Cardiovascular Complications in Clinical Practice: Current Perspectives

  2021cited by this paper
• A comprehensive review on time-tested anticancer drug doxorubicin.

  2021cited by this paper
• Regulated cell death pathways in doxorubicin-induced cardiotoxicity

  2021cited by this paper
• Cancer statistics, 2020

  2020cited by this paper
• Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic Reviews

  2020cited by this paper
• Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.

  2020cited by this paper
• Immune cell infiltration landscapes in pediatric acute myocarditis analyzed by CIBERSORT.

  2020cited by this paper
• Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia

  2020cited by this paper
• Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment-Related Cardiovascular Toxicity.

  2020cited by this paper
• Microalgae carotenoids intake: Influence on cholesterol levels, lipid peroxidation and antioxidant enzymes.

  2020cited by this paper
• Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model

  2020cited by this paper
• Immune Checkpoint Inhibitors-Related Cardiotoxicity.

  2020cited by this paper
• Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy

  2019cited by this paper
• Ferroptosis as a target for protection against cardiomyopathy

  2019cited by this paper
• Cancer and heart failure—more than meets the eye: common risk factors and co‐morbidities

  2018cited by this paper
• Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis.

  2018cited by this paper
• The increased expression of the inducible Hsp70 (HSP70A1A) in serum of patients with heart failure and its protective effect against the cardiotoxic agent doxorubicin

  2018cited by this paper
• Apigenin Attenuates Adriamycin-Induced Cardiomyocyte Apoptosis via the PI3K/AKT/mTOR Pathway

  2017cited by this paper
• Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival

  2017cited by this paper
• Immune‐related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia

  2017cited by this paper
• Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

  2016cited by this paper
• Deficiency in Cardiolipin Reduces Doxorubicin-Induced Oxidative Stress and Mitochondrial Damage in Human B-Lymphocytes

  2016cited by this paper
• Isoflavones: Anti-Inflammatory Benefit and Possible Caveats

  2016cited by this paper
• 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

  2016cited by this paper
• Soy Isoflavone Glycitin (4'‐Hydroxy‐6‐Methoxyisoflavone‐7‐D‐Glucoside) Promotes Human Dermal Fibroblast Cell Proliferation and Migration via TGF‐β Signaling

  2015cited by this paper
• Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors.

  2015cited by this paper
• Soy foods, isoflavones, and the health of postmenopausal women.

  2014cited by this paper
• Mitochondrial Topoisomerase I (Top1mt) Is a Novel Limiting Factor of Doxorubicin Cardiotoxicity

  2014cited by this paper
• Perspectives on the Role of Isoflavones in Prostate Cancer

  2013cited by this paper
• Cardiotoxicity associated with cancer therapy: pathophysiology and prevention strategies.

  2013cited by this paper
• Soy isoflavone: The multipurpose phytochemical (Review).

  2013cited by this paper
• Doxorubicin: the good, the bad and the ugly effect.

  2009cited by this paper
• The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.

  2007cited by this paper
• Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women.

  2007cited by this paper
• Antiproliferation of Hepatoma Cell and Progression of Cell Cycle as Affected by Isoflavone Extracts from Soybean Cake

  2007cited by this paper
• The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy.

  2007cited by this paper
• Anti-inflammatory effects of isoflavone powder produced from soybean cake.

  2007cited by this paper
• Functional components in soybean cake and their effects on antioxidant activity.

  2006cited by this paper
• Jamaican Cardiomyopathy

  2005cited by this paper
• Effect of daidzin, genistin, and glycitin on osteogenic and adipogenic differentiation of bone marrow stromal cells and adipocytic transdifferentiation of osteoblasts

  2005cited by this paper
• Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro.

  2004cited by this paper
• Isoflavones and skeletal health: are these molecules ready for clinical application?

  2003cited by this paper
• Different mechanisms of soy isoflavones in cell cycle regulation and inhibition of invasion.

  2002cited by this paper
• Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.

  2001cited by this paper
• Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention?

  2000cited by this paper
• Evolution of the Health Benefits of Soy Isoflavones

  1998cited by this paper
• Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States)

  1998cited by this paper
• Cardiotoxicity of adriamycin and related anthracyclines.

  1976cited by this paper

• Glycitein: A comprehensive review of its bioactivities, molecular mechanisms, and therapeutic potential.

  2025cites this paper
• Study of Lycium barbarum in the Treatment of Osteoradionecrosis of the Jaw: An Integration of Network Pharmacology With Experimental Validation

  2025cites this paper